Legend Biotech (LEGN) Current Leases (2019 - 2025)
Legend Biotech (LEGN) posted Current Leases of $7.4 million for Q4 2025, little changed on a QoQ basis from $7.4 million in Q3 2025, and up 54.17% year-over-year from $4.8 million in Q4 2024.
Legend Biotech (LEGN) Current Leases (2019 - 2025) Analysis & Trends
Legend Biotech's Current Leases history runs 7 years deep, the most recent figure standing at $7.4 million for Q4 2025.
- Quarterly Current Leases rose 54.17% year-over-year to $7.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.4 million (up 54.17% YoY) and the FY2025 annual result came in at $7.4 million, up 54.17% from the prior year.
- Current Leases was $7.4 million for Q4 2025 at Legend Biotech, roughly flat from $7.4 million in the prior quarter.
- Across five years, Current Leases topped out at $7.4 million in Q4 2025 and bottomed at $1673.0 in Q1 2021.
- A 5-year average of $3.7 million and a median of $3.6 million in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2021 — Current Leases sank 37.77% — and 2022, when it jumped 218070.95%.
- Legend Biotech's Current Leases stood at $911000.0 in 2021, then jumped by 291.11% to $3.6 million in 2022, then slipped by 10.89% to $3.2 million in 2023, then jumped by 51.18% to $4.8 million in 2024, then jumped by 54.17% to $7.4 million in 2025.
- Business Quant data shows LEGN's Current Leases at $7.4 million in Q4 2025, $7.4 million in Q3 2025, and $5.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 16.61 Mn |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | 7.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.40 Mn |
| Sep 30, 2025 | 7.37 Mn |
| Jun 30, 2025 | 5.91 Mn |
| Mar 31, 2025 | 5.34 Mn |
| Dec 31, 2024 | 4.80 Mn |
| Sep 30, 2024 | 4.34 Mn |
| Jun 30, 2024 | 3.33 Mn |
| Mar 31, 2024 | 3.12 Mn |
| Dec 31, 2023 | 3.18 Mn |
| Sep 30, 2023 | 2.92 Mn |
| Jun 30, 2023 | 3.56 Mn |
| Mar 31, 2023 | 4.60 Mn |
| Dec 31, 2022 | 3.56 Mn |
| Mar 31, 2022 | 3.65 Mn |
| Dec 31, 2021 | 911,000.00 |
| Sep 30, 2021 | 1.87 Mn |
| Jun 30, 2021 | 1.62 Mn |
| Mar 31, 2021 | 1,673.00 |
| Dec 31, 2020 | 1.46 Mn |
| Sep 30, 2020 | 2,543.00 |